Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella, Maria Cristina Campopiano, Michele Mantuano, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 9, pp. 782-792
Open Access | Times Cited: 870

Showing 1-25 of 870 citing articles:

The burden and risks of emerging complications of diabetes mellitus
Dunya Tomic, Jonathan E. Shaw, Dianna J. Magliano
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 9, pp. 525-539
Open Access | Times Cited: 634
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
Deepak Garg, Valliappan Muthu, Inderpaul Singh Sehgal, et al.
Mycopathologia (2021) Vol. 186, Iss. 2, pp. 289-298
Open Access | Times Cited: 560
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski, Martin Sebastian Winkler, Tomasz Skirecki, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 622-642
Open Access | Times Cited: 478
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 3, pp. 135-149
Open Access | Times Cited: 416
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, et al.
Nature Metabolism (2021) Vol. 3, Iss. 6, pp. 774-785
Open Access | Times Cited: 360
Risk Factors for Coronavirus Disease 2019 (COVID-19)–Associated Hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System
Jean Y. Ko, Melissa L. Danielson, Machell Town, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 11, pp. e695-e703
Open Access | Times Cited: 322
Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study
Kathryn E. Mansfield, Rohini Mathur, John Tazare, et al.
The Lancet Digital Health (2021) Vol. 3, Iss. 4, pp. e217-e230
Open Access | Times Cited: 309
An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications
Uday Hossain, Abhishek Das, Sumit Ghosh, et al.
Food and Chemical Toxicology (2020) Vol. 145, pp. 111738-111738
Open Access | Times Cited: 290
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 91-100
Open Access | Times Cited: 268
Proportion of newly diagnosed diabetes in COVID‐19 patients: A systematic review and meta‐analysis
Thirunavukkarasu Sathish, Nitin Kapoor, Yingting Cao, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 3, pp. 870-874
Open Access | Times Cited: 243
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 212
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
Awadhesh Kumar Singh, Ritu Singh
Diabetes Research and Clinical Practice (2020) Vol. 167, pp. 108382-108382
Open Access | Times Cited: 174
New onset diabetes, type 1 diabetes and COVID-19
Sirisha Kusuma Boddu, Geeta Aurangabadkar, Mohammad Shafi Kuchay
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 2211-2217
Open Access | Times Cited: 174
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Kamlesh Khunti, Peter Knighton, Francesco Zaccardi, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 5, pp. 293-303
Open Access | Times Cited: 174
Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020
John Dennis, Bilal A. Mateen, Raphael Sonabend, et al.
Diabetes Care (2020) Vol. 44, Iss. 1, pp. 50-57
Open Access | Times Cited: 170
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1028-1040.e4
Open Access | Times Cited: 167
Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
Andrew B. Crouse, Tiffany Grimes, Peng Li, et al.
Frontiers in Endocrinology (2021) Vol. 11
Open Access | Times Cited: 167
Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care
Nicolas J. Pillon, Ruth J. F. Loos, Sally M. Marshall, et al.
Cell (2021) Vol. 184, Iss. 6, pp. 1530-1544
Open Access | Times Cited: 167
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
Eleni Korompoki, Maria Gavriatopoulou, Rachel Hicklen, et al.
Journal of Infection (2021) Vol. 83, Iss. 1, pp. 1-16
Open Access | Times Cited: 159
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study
Abdullah Alguwaihes, Mohammed E. Al‐Sofiani, Maram Megdad, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 147
Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis
Ting Zhang, Qimin Mei, Zhaocai Zhang, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 121
Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Guillaume Beltramo, Jonathan Cottenet, Anne‐Sophie Mariet, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 6, pp. 2004474-2004474
Open Access | Times Cited: 118
A Review of Coronavirus Disease Covid-19
Swapnali Zore
International Journal of Advanced Research in Science Communication and Technology (2021), pp. 104-115
Open Access | Times Cited: 117
Virus Infections and Host Metabolism—Can We Manage the Interactions?
Deepak Sumbria, Engin Berber, Manikannan Mathayan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 116
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study
Aidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, et al.
The Lancet Regional Health - Europe (2021) Vol. 4, pp. 100105-100105
Open Access | Times Cited: 113
Page 1 - Next Page

Scroll to top